Article alert! MAX to MYCN ratio drives clinical outcome of neuroblastoma
Childhood neuroblastoma is the most common cancer that occurs in infancy. The MYCN oncogene has been shown to be a strong indicator for this cancer. MYCN is a transcription factor that requires the expression of MAX to exert its function. In this new study, researchers illustrate that the MAX to MYCN ratio accounts for tumour progression and[…]